Financing and Investment Activities in China's Mobility Industry From 2012 to 2022
CRO ClinChoice Raises USD 150 Mn in Series E Round
2015 is the inflection point for the development of China's innovative drug industry and CRO (clinical research organization). On July 22nd, 2015, after CDE (Center For Drug Evaluation) released the announcement on self-examination and verification of drug clinical trial data, the supervision of Chinese clinical trials moved towards standardization. The investment and financing of innovative drugs in China continued to increase, laying the foundation for the growth of CRO.
Jul 05, 2022 08:17 PM
Consumer Electronics: ESG Emerging as a Hidden Highlight
Nov 30, 2023 10:11 PM
JALA Group: A Perfect Answer to Creating Green Beauty
Nov 30, 2023 06:22 PM